mannitol has been researched along with cyclosporine in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (26.47) | 18.2507 |
| 2000's | 11 (32.35) | 29.6817 |
| 2010's | 14 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Gilon, C; Hess, S; Hoffman, A; Jelinek, R; Ovadia, O; Qadri, B; Salitra, Y; Senderovich, H; Shalev, DE; Sheynis, T; Yehezkel, T | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Biesenbach, G; Brücke, P; Grafinger, P; Gross, C; Hartl, P; Kaiser, W; Stuby, U; Zazgornik, J | 1 |
| Bonal, J; Bonet, J; Borrás, M; Caralps, A; Lauzurica, R; Romero, R; Serra, A; Teixidó, J; Torguet, P | 1 |
| Sadrieh, N; Thomas, PE | 1 |
| Hietala, SO; Högström, B; Rooth, P | 1 |
| Arribas, MJ; Carrera, A; Cuervas-Mons, V; de la Quintana, B; García-Guiral, M; Gómez-Arnau, J; Pascual, E; Pensado, A | 1 |
| Peeters, J; Roels, L; Vanrenterghem, Y | 1 |
| Hosoya, KI; Kim, KJ; Lee, VH | 1 |
| Dubose, TD; Massin, EK; Visweswaran, P | 1 |
| Siesjö, BK; Yoshimoto, T | 1 |
| Auchère, D; Banide, H; Farinotti, R; Lacour, B; Leroy, C; Tardivel, S; Veau, C | 1 |
| Asano, Y; Ishibashi, S; Miyata, Y; Muto, S; Okada, K | 1 |
| Asano, Y; Miyata, Y; Muto, S | 1 |
| Broekemeier, KM; Crouser, ED; Gadd, ME; Huff, JE; Julian, MW; Pfeiffer, DR; Robbins, KA | 1 |
| Coccia, C; Costa, MG; Marco, PD; Monaco, S; Pietropaoli, P; Pompei, L; Rocca, GD; Scudeller, L | 1 |
| Chakrabarti, SK; Lemieux, N; M'Bemba-Meka, P | 1 |
| Barletta, J; Bergström, M; Blomquist, G; Långström, B; Syvänen, S | 1 |
| Bi, XL; Chen, LT; Di, LQ; Du, Q; Zhou, W | 1 |
| Chan, HK; Fukushige, K; Kwok, PC; Prud'homme, RK; Yamasaki, K | 1 |
| Dhein, S; Hoyer, A; Kempfert, J; Mohr, FW; Pritzwald-Stegmann, P | 1 |
| Danjo, K; Mizutani, D; Niwa, T | 1 |
| Gobec, M; Gurwitz, D; Markovič, T; Mlinarič-Raščan, I | 1 |
| Chan, HK; Onoue, S; Prud'homme, RK; Sato, H; Seto, Y; Suzuki, H; Wong, J; Yakushiji, K | 1 |
| Chan, HK; Hamao, S; Onoue, S; Prud'homme, RK; Sato, H; Seto, Y; Suzuki, H; Wong, J | 1 |
| Chan, HK; Guerra, HV; Leung, SS; Prud'homme, RK; Samnick, K; Wong, J | 1 |
| Birch, D; Christophersen, PC; Diedrichsen, RG; Mu, H; Nielsen, HM | 1 |
| Chew, HC; Dhital, KK; Doyle, A; Gao, L; Hicks, M; Jabbour, A; Macdonald, PS; Qui, MR; Villanueva, JE | 1 |
1 review(s) available for mannitol and cyclosporine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for mannitol and cyclosporine
| Article | Year |
|---|---|
Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial.
Topics: Acute Kidney Injury; Adult; Aged; Blood Urea Nitrogen; Blood Volume; Cyclosporine; Diuretics; Dopamine; Dopamine Agonists; Female; Fenoldopam; Furosemide; Hemodynamics; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Liver Transplantation; Male; Mannitol; Middle Aged; Monitoring, Intraoperative; Pilot Projects; Postoperative Complications; Urodynamics | 2004 |
32 other study(ies) available for mannitol and cyclosporine
| Article | Year |
|---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability.
Topics: Animals; Biological Transport; Caco-2 Cells; Cell Membrane Permeability; Cyclization; Humans; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Liposomes; Magnetic Resonance Spectroscopy; Mannitol; Methylation; Microvilli; Oligopeptides; Peptides, Cyclic; Protein Conformation; Rats; Structure-Activity Relationship | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Severe tubulopathy and kidney graft rupture after coadministration of mannitol and ciclosporin.
Topics: Adult; Biopsy; Creatinine; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney; Kidney Diseases; Kidney Transplantation; Kidney Tubules; Male; Mannitol; Rupture, Spontaneous; Transplantation, Homologous | 1992 |
Hydration and mannitol reduce the need for dialysis in cadaveric kidney transplant recipients treated with CyA.
Topics: Adult; Antilymphocyte Serum; Cadaver; Cyclosporine; Fluid Therapy; Histocompatibility Testing; Humans; Immunosuppression Therapy; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Mannitol; Middle Aged; Prednisone; Renal Dialysis | 1992 |
Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins.
Topics: Aging; Animals; Antibodies, Monoclonal; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Catalysis; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Induction; Erythromycin; Female; Glutathione; Isoenzymes; Kidney; Male; Mannitol; Microsomes; Microsomes, Liver; Oxidoreductases, N-Demethylating; Protein Binding; Proteins; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Testosterone; Tritium; Troleandomycin | 1994 |
In vivo fluorescence microscopy of microcirculation in the renal cortex of mice. Part III. Effects of mannitol and iohexol infusions after pretreatment with cyclosporin A.
Topics: Animals; Cyclosporine; Female; Infusions, Intravenous; Iohexol; Kidney Cortex; Mannitol; Mice; Microcirculation; Microscopy, Fluorescence | 1993 |
Incidence and risk factors of early acute renal failure in liver transplant patients.
Topics: Acute Kidney Injury; Analysis of Variance; Cyclosporine; Dopamine; Humans; Incidence; Liver Transplantation; Mannitol; Postoperative Complications; Prednisone; Retrospective Studies; Risk Factors; Time Factors | 1993 |
Delayed graft function as principal correlate of kidney allograft outcome in a single-center multivariate analysis.
Topics: Actuarial Analysis; Adenosine; Adult; Age Factors; Allopurinol; Cadaver; Cyclosporine; Female; Glucose; Glutathione; Graft Survival; Humans; Hypertonic Solutions; Immunosuppressive Agents; Insulin; Kidney Transplantation; Male; Mannitol; Middle Aged; Multivariate Analysis; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Procaine; Raffinose; Regression Analysis; Sex Factors; Time Factors; Tissue Donors; Treatment Outcome | 1996 |
Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Blotting, Western; Caco-2 Cells; Calcium Channel Blockers; Cell Membrane; Cyclosporine; Dexamethasone; Diuretics, Osmotic; Glucocorticoids; Humans; Immunosuppressive Agents; Mannitol; Permeability; Time Factors; Verapamil | 1996 |
Mannitol-induced acute renal failure.
Topics: Acute Kidney Injury; Aged; Cyclosporine; Diuresis; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mannitol; Osmosis | 1997 |
Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia.
Topics: Animals; Blood Glucose; Blood-Brain Barrier; Body Temperature; Brain Injuries; Carbon Dioxide; Carotid Arteries; Cyclosporine; Diuretics, Osmotic; Hydrogen-Ion Concentration; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Injections, Intra-Arterial; Ischemic Attack, Transient; Male; Mannitol; Osmosis; Oxygen; Rats; Rats, Wistar; Sodium Chloride; Tacrolimus; Wounds, Stab | 1999 |
Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Creatinine; Cyclosporine; Intestinal Mucosa; Jejunum; Kidney Failure, Chronic; Male; Mannitol; Pharmaceutical Preparations; Rats; Rats, Sprague-Dawley; Rhodamine 123; RNA, Messenger; Verapamil | 2001 |
P-gp-induced modulation of regulatory volume increase occurs via PKC in mouse proximal tubule.
Topics: Actin Cytoskeleton; Androstadienes; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Carcinogens; Chromones; Colchicine; Cyclosporine; Cytochalasin B; Diuretics, Osmotic; Enzyme Inhibitors; Hypertonic Solutions; Kidney Tubules, Proximal; Male; Mannitol; Mice; Mice, Knockout; Microtubules; Morpholines; Naphthalenes; Phorbols; Phosphatidylinositol 3-Kinases; Protein Kinase C; Signal Transduction; Staurosporine; Tetradecanoylphorbol Acetate; Verapamil; Wortmannin | 2002 |
Hyperosmotic mannitol activates basolateral NHE in proximal tubule from P-glycoprotein null mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buffers; Calibration; Cyclosporine; Diuretics, Osmotic; Enzyme Activation; Hydrogen-Ion Concentration; In Vitro Techniques; Kidney Tubules, Proximal; Kinetics; Mannitol; Mice; Mice, Knockout; Perfusion; Protein Kinase C; Sodium-Hydrogen Exchangers; Solutions | 2002 |
Quantitation of cytochrome c release from rat liver mitochondria.
Topics: Adenylate Kinase; Animals; Blotting, Western; Chromatography, High Pressure Liquid; Cyclosporine; Cytochromes c; Horses; Mannitol; Mitochondria, Liver; Mitochondrial Swelling; Osmolar Concentration; Permeability; Potassium Chloride; Rats; Sensitivity and Specificity; Sucrose | 2003 |
Role of oxidative stress, mitochondrial membrane potential, and calcium homeostasis in nickel sulfate-induced human lymphocyte death in vitro.
Topics: Acetylcysteine; Calcium; Catalase; Cell Death; Cyclosporine; Deferoxamine; Glutathione; Homeostasis; Humans; Hydrogen Peroxide; Lymphocytes; Mannitol; Membrane Potentials; Mitochondria; Nickel; Oxidative Stress; Thiourea | 2005 |
PET-evaluated transport of [11C]hydroxyurea across the rat blood-brain barrier--lack of influence of cyclosporin and probenecid.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Hydroxyurea; Male; Mannitol; Positron-Emission Tomography; Probenecid; Rats; Rats, Sprague-Dawley; Tissue Distribution; Verapamil | 2007 |
[Intestinal absorption of forsythoside A by rat circulation in situ].
Topics: Animals; Colon; Cyclosporine; Digoxin; Dose-Response Relationship, Drug; Duodenum; Edetic Acid; Glycosides; Hydrogen-Ion Concentration; Ileum; Intestinal Absorption; Jejunum; Male; Mannitol; Midazolam; Rats; Rats, Sprague-Dawley | 2010 |
Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former.
Topics: Administration, Inhalation; Aerosols; Chemical Precipitation; Chemistry, Pharmaceutical; Crystallization; Cyclosporine; Drug Carriers; Drug Compounding; Hydrophobic and Hydrophilic Interactions; Immunosuppressive Agents; Kinetics; Mannitol; Nanoparticles; Nanotechnology; Powders; Solubility; Surface Properties; Technology, Pharmaceutical | 2011 |
Cardioprotective effects of low-dose cyclosporin A added to histidine-tryptophan-ketoglutarate cardioplegia solution prior to total myocardial ischemia: an in vitro rabbit heart study.
Topics: Adenosine Triphosphate; Animals; Cardioplegic Solutions; Cardiotonic Agents; Cyclosporine; Glucose; Heart; Immunosuppressive Agents; Male; Malondialdehyde; Mannitol; Myocardial Reperfusion Injury; Oxygen; Potassium Chloride; Procaine; Rabbits; Ventricular Pressure | 2011 |
Spray freeze-dried porous microparticles of a poorly water-soluble drug for respiratory delivery.
Topics: Aerosols; Cyclosporine; Freeze Drying; Mannitol; Particle Size; Pharmaceutical Preparations; Porosity; Respiratory Mucosa; Solubility; tert-Butyl Alcohol; Water | 2012 |
Characterization of human lymphoblastoid cell lines as a novel in vitro test system to predict the immunotoxicity of xenobiotics.
Topics: Animals; Benzo(a)pyrene; Cell Line; Cyclosporine; Furosemide; Humans; Inhibitory Concentration 50; Interferon-gamma; Interleukin-10; Interleukin-2; Interleukin-4; Interleukin-6; Leukocytes, Mononuclear; Lymphocytes; Mannitol; Toxicity Tests; Trialkyltin Compounds; Tumor Necrosis Factor-alpha; Urethane; Verapamil; Xenobiotics | 2015 |
Biopharmaceutical Evaluation of Novel Cyclosporine A Nano-matrix Particles for Inhalation.
Topics: Administration, Inhalation; Animals; Biomarkers; Chemistry, Pharmaceutical; Cyclosporine; Inflammation; Male; Mannitol; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley | 2016 |
New nano-matrix oral formulation of nanoprecipitated cyclosporine A prepared with multi-inlet vortex mixer.
Topics: Administration, Oral; Animals; Biological Availability; Chemical Precipitation; Chemistry, Pharmaceutical; Cyclosporine; Drug Delivery Systems; Excipients; Mannitol; Nanoparticles; Particle Size; Powders; Rats; Solubility | 2017 |
Porous mannitol carrier for pulmonary delivery of cyclosporine A nanoparticles.
Topics: Administration, Inhalation; Chemistry, Pharmaceutical; Cyclosporine; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Drug Storage; Freeze Drying; Hydrophobic and Hydrophilic Interactions; Immunosuppressive Agents; Lecithins; Lung; Mannitol; Nanoparticles; Porosity; Vitamin E | 2017 |
Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
Topics: Caco-2 Cells; Cell Survival; Coculture Techniques; Cyclosporine; Deamino Arginine Vasopressin; Fenofibrate; HT29 Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mannitol; Metoprolol; Models, Biological; Mucus; Ovalbumin; Permeability | 2018 |
Cyclosporine A as a Cardioprotective Agent During Donor Heart Retrieval, Storage, or Transportation: Benefits and Limitations.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy-Related Protein-1 Homolog; Cardioplegic Solutions; Cold Ischemia; Cyclosporine; Disaccharides; Electrolytes; Glutamates; Glutathione; Heart; Heart Transplantation; Histidine; Isolated Heart Preparation; Male; Mannitol; Mitochondria, Heart; Nitric Oxide Synthase Type III; Organ Preservation; Organ Preservation Solutions; Phosphorylation; Rats, Wistar; Recovery of Function; Time Factors | 2019 |